Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation Expense
Ratios

Inogen (INGN) EBIAT (2016 - 2022)

Inogen (INGN) has disclosed EBIAT for 10 consecutive years, with -$9.5 million as the latest value for Q3 2022.

  • On a quarterly basis, EBIAT fell 178.08% to -$9.5 million in Q3 2022 year-over-year; TTM through Sep 2022 was -$15.1 million, a 244.48% decrease, with the full-year FY2021 number at -$6.3 million, down 8.65% from a year prior.
  • EBIAT was -$9.5 million for Q3 2022 at Inogen, up from -$22.9 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $16.4 million in Q3 2018 to a low of -$22.9 million in Q4 2021.
  • A 5-year average of $3.2 million and a median of $5.2 million in 2019 define the central range for EBIAT.
  • Peak YoY movement for EBIAT: soared 1757.59% in 2018, then tumbled 346.73% in 2021.
  • Inogen's EBIAT stood at $10.0 million in 2018, then tumbled by 113.69% to -$1.4 million in 2019, then tumbled by 272.44% to -$5.1 million in 2020, then tumbled by 346.73% to -$22.9 million in 2021, then surged by 58.45% to -$9.5 million in 2022.
  • Per Business Quant, the three most recent readings for INGN's EBIAT are -$9.5 million (Q3 2022), -$22.9 million (Q4 2021), and $12.2 million (Q3 2021).